Welcome to LookChem.com Sign In|Join Free

CAS

  • or

379228-45-2

Post Buying Request

379228-45-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

379228-45-2 Usage

Description

5-Chloro-1,3-benzodioxol-4-amine is an organic compound characterized by its chemical structure that features a benzodioxol ring with a chlorine atom at the 5th position and an amine group at the 4th position. 5-CHLORO-1,3-BENZODIOXOL-4-AMINE is known for its reactivity in substitution reactions and has potential applications in various industries due to its unique chemical properties.

Uses

Used in Pharmaceutical Industry:
5-Chloro-1,3-benzodioxol-4-amine is used as a synthetic intermediate for the preparation of various pharmaceutical compounds. Its ability to undergo substitution reactions makes it a valuable building block in the synthesis of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, 5-chloro-1,3-benzodioxol-4-amine serves as a key intermediate for the production of various organic compounds. Its reactivity in substitution reactions allows for the creation of a wide range of derivatives with diverse properties and potential uses.
For example, 5-chloro-1,3-benzodioxol-4-amine was used to prepare chloro(methylthio)thiazolopyridine via a substitution reaction. This demonstrates its utility in the synthesis of complex organic molecules with specific functional groups, which can be further utilized in various applications, such as the development of new drugs or advanced materials.

Check Digit Verification of cas no

The CAS Registry Mumber 379228-45-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,9,2,2 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 379228-45:
(8*3)+(7*7)+(6*9)+(5*2)+(4*2)+(3*8)+(2*4)+(1*5)=182
182 % 10 = 2
So 379228-45-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClNO2/c8-4-1-2-5-7(6(4)9)11-3-10-5/h1-2H,3,9H2

379228-45-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Chlorobenzo[d][1,3]dioxol-4-amine

1.2 Other means of identification

Product number -
Other names 5-CHLORO-1,3-BENZODIOXOL-4-AMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:379228-45-2 SDS

379228-45-2Relevant articles and documents

Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src

Plé, Patrick A.,Green, Tim P.,Hennequin, Laurent F.,Curwen, Jon,Fennell, Michael,Allen, Jack,Lambert-Van Der Brempt, Christine,Costello, Gerard

, p. 871 - 887 (2007/10/03)

Deregulated activity of the nonreceptor tyrosine kinase c-Src is believed to result in signal transduction, cytoskeletal and adhesion changes, ultimately promoting a tumor-invasive phenotype. We report here the discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of the c-Src enzyme. Special attention was directed toward finding inhibitors selective against KDR tyrosine kinase in order to ensure that the in vivo profile of a specific Src inhibitor could be determined. The 4-aminobenzodioxole quinazoline series gave compounds with excellent potency and selectivity. The most interesting compounds were evaluated in vivo and displayed good pharmacokinetics following oral dosing. Compounds such as the aminobenzodioxoles were shown to be potent inhibitors of tumor growth in a c-Src-transformed 3T3 xenograft model in vivo, resulting in more than 90% growth inhibition at doses as low as 6 mg/kg po once daily. Src tyrosine kinase inhibitors such as these may provide a novel therapeutic modality for targeting cancer invasion and metastasis.

SUBSTITUTED 3-CYANOQUINOLINES AS MEK INHIBITORS

-

Page 71; 94, (2010/11/30)

The invention concerns quinoline derivatives of Formula (I) wherein each of Z1, m, R1, n, R3, Z2 and R14 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive or anti-proliferative agent in the containment and/or treatment of solid tumour disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 379228-45-2